Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] SK hynix (000660 / SKHY) – Decision on Rights Offering  / 2026-03-03 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – Investor Relations (IR) Holding Announcement / 2025-07-08 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – Change in Chief Executive Officer (Informational Disclosure) / 2025-11-28 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | AI & Automotive Expansion · High-End Mix Improvement · 2025 FCBGA Growth / 2024-10-30 RESEARCH
  • [Research] SK hynix (000660 / SKHY) – Kyobo | HBM4 · Product Mix · LTA / 2026-07-30 RESEARCH
  • [Research] Samsung Electro-Mechanics (009150) – SK Securities | MLCC Utilization · Supply Tightness · Margin Expansion / 2024-08-01 RESEARCH
  • [Disclosure] Samsung Electronics (005930) – Provisional Consolidated Financial Performance (Fair Disclosure) / 2024-04-05 Disclosures
  • [Disclosure] PSK Holdings (031980) – Change in Revenue or Income Structure Exceeding 30% (15% for Large Corporations) / 2024-02-07 Semiconductors

[Disclosure] Daeduck Electronics (353200) – Provisional Operating Results (Consolidated Financial Basis) / 2025-11-04

Posted on November 4, 2025August 3, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Daeduck Electronics disclosed that its Q3 2025 consolidated operating profit reached KRW 24.45B, up 165.2% year-on-year and up 1,210.1% quarter-on-quarter.

📊 Key Disclosure Contents & Major Figures

1. Q3 2025 Consolidated Provisional Financial Results

  • Revenue:
    • Q3 2025: KRW 286.17B (KRW 286,173M) / (+16.4% QoQ, +23.0% YoY)
    • Q2 2025: KRW 245.86B (KRW 245,858M)
    • Q3 2024: KRW 232.65B (KRW 232,654M)
  • Operating Profit:
    • Q3 2025: KRW 24.45B (KRW 24,448M) / (+1,210.1% QoQ, +165.2% YoY)
    • Q2 2025: KRW 1.87B (KRW 1,866M)
    • Q3 2024: KRW 9.22B (KRW 9,218M)
  • Income Before Income Taxes:
    • Q3 2025: KRW 28.85B (KRW 28,854M) / (Turned to Profit QoQ, +341.6% YoY)
    • Q2 2025: -KRW 1.90B (-KRW 1,901M)
    • Q3 2024: KRW 6.53B (KRW 6,533M)
  • Net Income (Attributable to Owners of Parent):
    • Q3 2025: KRW 23.28B (KRW 23,279M) / (+428.0% QoQ, +349.7% YoY)
    • Q2 2025: KRW 4.41B (KRW 4,409M)
    • Q3 2024: KRW 5.18B (KRW 5,177M)

2. Q3 2025 Cumulative Consolidated Provisional Financial Results

  • Cumulative Revenue: KRW 747.41B (KRW 747,407M) / (+9.0% YoY from KRW 685.66B)
  • Cumulative Operating Profit: KRW 20.11B (KRW 20,112M) / (+16.7% YoY from KRW 17.24B)
  • Cumulative Income Before Income Taxes: KRW 20.69B (KRW 20,688M) / (-15.6% YoY from KRW 24.51B)
  • Cumulative Net Income: KRW 21.99B (KRW 21,987M) / (+13.5% YoY from KRW 19.38B)

3. Information Provision and IR Details

  • Target Audience: Institutional investors, general investors, and analysts
  • Date & Time: November 04, 2025, at 16:00
  • Event Name: Q3 2025 Earnings Presentation
  • Department in Charge: Finance Team IR Part (+82-31-8040-8039)

4. Other Important Matters

  • These provisional figures are consolidated results based on K-IFRS and are subject to change during the accounting review by external auditors.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Finalized Figures Through External Audit Review

This disclosure provides preliminary operating results prior to the completion of the external auditor’s accounting review. Checking whether these provisional figures for revenue and operating profit are confirmed without adjustments following the external audit review is important to verify the accuracy of the financial results. Relevant details can be verified in future periodic reports such as quarterly or semi-annual reports.

📢 Disclaimer & Source Notice

Fact Source: Financial Supervisory Service DART

Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] Celltrion (068270) – Execution of License-in Agreement for Novel Drug Candidates for Rare Autoimmune Diseases / 2025-11-04
Next Post: [Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-11-04

Related Posts

  • [Disclosure] LEENO Industrial (058470) – Results of Annual General Meeting of Shareholders / 2026-03-26 Semiconductors
  • [Disclosure] KEPCO (015760 / KEP) – Decision on Cash and In-Kind Dividend / 2026-02-26 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Resolution on Convening General Meeting of Shareholders / 2026-03-04 Disclosures
  • [Disclosure] Celltrion (068270) – CT-P13 SC (Zymfentra) Europe Phase 3 Clinical Trial Plan Application (Part 1 & 2) (Rheumatoid Arthritis Patients) / 2026-07-24 Disclosures
  • [Disclosure] Celltrion (068270) – Approval of IND Amendment for CT-P51 (Keytruda Biosimilar) Korea Phase 3 Clinical Trial / 2026-04-24 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Provisional Consolidated Financial Results / 2025-07-31 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Treasury Stock Acquisition Decision / 2024-11-15 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Investor Relations (IR) Holding / 2024-02-07 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Reference Price for Interim (Quarterly) Ex-Dividend (Hyundai Motor Preferred) / 2026-05-27 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – New Facility Investment (Voluntary Disclosure) / 2025-06-20 Semiconductors
  • [Disclosure] Samsung Electronics(005930) – (Correction) Future Business and Management Plans (Fair Disclosure) / 2024-01-31 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract / 2024-12-17 Disclosures
  • [Disclosure] Celltrion (068270) – Filing / Application of Lawsuit (Management Control Dispute) / 2025-12-18 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract (Voluntary Disclosure) / 2025-12-22 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme